What does a prostate-specific antigen (PSA) level of 6.87 ng/mL indicate?

What Does a PSA of 6.87 ng/mL Mean?

A PSA level of 6.87 ng/mL is elevated and indicates a significantly increased risk of prostate cancer that warrants urological evaluation and likely prostate biopsy.

Clinical Significance

Your PSA of 6.87 ng/mL falls well above the traditional threshold of 4.0 ng/mL that has been the standard indication for prostate biopsy since the 1980s 1. This level places you in a risk category where approximately 30-35% of men will be found to have prostate cancer on biopsy 2.

What This Number Tells Us

Cancer Risk Stratification:

• PSA levels between 4-10 ng/mL (your range) carry substantial cancer risk
• About 70% of men in this range will have organ-confined disease if cancer is present 3
• The risk of pelvic lymph node metastases is approximately 5% when PSA is ≤10 ng/mL 3

Important Context:

• PSA is not cancer-specific—it can be elevated by benign prostatic hyperplasia (BPH), prostatitis, urinary tract infections, or prostate trauma 4
• However, at 6.87 ng/mL, the probability of cancer is high enough that further evaluation is clearly indicated

Recommended Next Steps

You should undergo urological consultation for:

1. Digital rectal examination (DRE) - A prostatic nodule or induration would further increase cancer suspicion and make biopsy more urgent 1, 4

2. Confirmatory PSA testing - Repeat the PSA to rule out transient elevation from benign causes 4

3. Consider additional biomarkers before biopsy to refine risk assessment 2:

   • Percent free PSA (<10% suggests higher cancer risk)
   • 4Kscore or phi testing
   • These can help determine if immediate biopsy is needed or if closer monitoring is appropriate

4. Prostate biopsy - This is the standard recommendation when confirmed PSA is >4.0 ng/mL 1

Critical Caveats

Medication Effects:

• If you're taking 5α-reductase inhibitors (finasteride or dutasteride), these medications decrease PSA by approximately 50% 2. Your "true" PSA would be roughly double the measured value, making evaluation even more urgent.

Age Considerations:

• The significance of this PSA level varies by age
• Younger men (45-60 years) with PSA >6.87 ng/mL have higher concern for clinically significant cancer
• Men over 75 years with limited life expectancy may not benefit from aggressive workup unless symptoms are present 2

Velocity Matters:

• If you have prior PSA measurements, the rate of rise is important
• A PSA increase >1.0 ng/mL per year raises concern for cancer even if absolute values are in the "gray zone" 1
• PSA velocity >2.0 ng/mL in the year before diagnosis is associated with 10-fold greater risk of prostate cancer death 3

What to Discuss with Your Doctor

Before proceeding with biopsy, you should have a shared decision-making conversation about:

• Your personal risk factors (family history, race—African-American men have higher risk)
• The possibility of detecting clinically insignificant cancer that may never cause harm
• Your life expectancy and overall health status
• Whether additional testing (multiparametric MRI) might help target biopsy to suspicious areas 2

Bottom line: A PSA of 6.87 ng/mL is not normal and requires urological evaluation. The most likely next step is prostate biopsy after confirming the elevation and performing DRE, though additional risk stratification tools may help refine the decision.